Harmony Biosciences Holdings's total assets for Q3 2025 were $1.21B, an increase of 9.04% from the previous quarter. HRMY total liabilities were $373.10M for the fiscal quarter, a 11.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.